Skip to main content

Table 1 Demographic and clinical characteristic in the 2,826 deaths analyzed, by diagnosed asthma, COPD or neither of the two diseases (without asthma/COPD)

From: “Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study”

 

Asthma (n = 82)

COPD (n = 283)

Without asthma/COPD (n = 2.461)

Value of p

    

0.350*

Age (years), mean (SD)

75 (15)

76 (9)

75 (14)

0.690

CI 95%

(60–80)

(68–85)

(61–89)

0.310

Sex n(%)

    

– Men

18 (22)

256 (90.4)

1280 (53.0)

< 0.001 *

– Women

64 (78)

27 ( 9.6)

1171 (47.0)

< 0.001

< 0.001

Smoking n (%)

    

– Smoker

8 (10.5)

64 (22.7)

295 (13.8)

< 0.001 *

– Former smoker

9 (11.8)

208 (73.6)

547 (25.5)

0.008

– Non smoker

58 (77.7)

10 (3.7)

1300 (60.7)

< 0.001

Diabetes n (%)

   

0.266*

28 (34.6)

77 (27.7)

652 (26.9)

0.081

0.417

Hyperlipidaemia n (%)

   

0.035*

26 (32.1)

58 (21.5)

590 (24.8)

0.090

   

0.121

AHT n (%)

   

0.148*

43 (52.8)

184 (65.0)

1321 (53.7)

0.529

0.030

Obesity BMI > 30 kg/m2 n (%)

   

0.033*

27 (32.8)

57 (20.1)

339 (13.8)

< 0.001

0.011

BMI, mean (SD) CI 95%

   

0.061*

27.6 (7)

25.2 (5.4)

23.7 (6)

< 0.001

 

(20,6-34,6)

(19,8-30,6)

(17,7-29,7)

0.002

  1. Footnote:
  2. Values represent means (standard deviation) or number of cases (percentage).
  3. AHT, arterial hypertension; BMI, body mass index.
  4. *comparisons between asthma group and COPD group
  5. †comparisons between asthma group and group with neither asthma nor COPD.
  6. ¶comparisons between COPD group and group with neither asthma nor COPD.
  7. comparisons between groups using the χ2 test for the categoric variables; and for the ordinal or quantitative variables, using the ANOVA test, or the Kruskall-Wallis test if the values did not present a normal distribution.
  8. We considered significanta p-value < 0.005.